Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 1074-1078

  Brun, Valérie ^a   Neveu, Virginie ^a   Pers, Yves Marie ^b   Fabre, Sylvie ^b   Quatannens, Brigitte ^a   Bastian, Hervé ^a   Clerget Chossat, Nathalie ^a   Jorgensen, Christian ^b   Foussat, Arnaud ^a  

^a TxCell SA   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Immunotherapy; Regulatory Tr1 cells; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MALE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 84860403980     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.03.001     Document Type: Article

References (31)

1. Brusko TM, Putnam AL, Bluestone JA. Humanregulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev Jun 2008;223:371-90. (Pubitemid 351986182)
2. Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, et al. CD4+ Tregulatory cells: toward therapy for human diseases. Immunol Rev Jun 2008;223: 391-421. (Pubitemid 351986179)
3. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature Oct 16 1997;389:737-42. (Pubitemid 27458961)
4. Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol Nov 15 2003;171(10):5018-26. (Pubitemid 37432782)
5. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2- inducing cytokines. J Exp Med Mar 4 2002;195:603-16. (Pubitemid 34461505)
6. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-53.
7. Urry Z, Xystrakis E, Richards DF, McDonald J, Sattar Z, Cousins DJ, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. Clin Invest Feb 2009;119:387-98.
8. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol Nov 2009;39:3147-59.
9. Larché Mark, Wraith David C. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11:69-76.
10. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J Exp Med 2007;204:33-9. (Pubitemid 46148753)
11. Kavousanaki M, Makrigiannakis A, Boumpas D, Verginis P. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy. Arthritis Rheum Jan 2010;62:53-63.
12. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, et al. A Phase I trial with transgenic bacteria expressing Interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006;4:754-9. (Pubitemid 43841860)
13. Guichelaar T, Brink C,Kooten PJ, Berlo SE, Broeren CP, van Eden W, et al. Autoantigenspecific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J Immunol 2008;180:1373-81.
14. Vaz A, Lisse J, Rizzo W, Albani S. Discussion: DMARDs and biologic therapies in the management of inflammatory joint diseases. Expert Rev Clin Immunol May 2009;5(3):291-9.
15. Choi SI, Brahn E. Rheumatoid arthritis therapy: advances from bench to bedside. Autoimmunity 2010;43(7):478-82.
16. Esensten JH, Wofsy D, Bluestone JA. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol Oct 2009;5:560-5.
17. Brun V, Bastian H, Neveu V, Foussat A. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int Immunopharmacol May 2009;9(5):609-13.
18. Cai Z, Brunmark A, Jackson MR, Loh D, Peterson PA, Sprent J. Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells. Proc Natl Acad Sci USA Dec 10 1996;93:14736-41. (Pubitemid 26419038)
19. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med Jun 7 2004;199:1567-75. (Pubitemid 38780411)
20. You S, Chen C, Lee WH, Brusko T, Atkinson M, Liu CP. Presence of diabetesinhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J Immunol Dec 1 2004;173:6777-85. (Pubitemid 39541064)
21. Cao D, Malmström V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol Jan 2003;33: 215-23. (Pubitemid 36157659)
22. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach E, Lipsky PE. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006: 253-61. (Pubitemid 43990636)
23. Wan S, Xia C, Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+ CD25+ T cell regulatory functions. J Immunol 2007;178:271-9. (Pubitemid 46033610)
24. Peluso I, Fantini MC, Fina D, Caruso R, Boirivant M, MacDonald TT, et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol Jan 15 2007;178:732-9. (Pubitemid 46095145)
25. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033-6. (Pubitemid 36222922)
26. Astier AL, Hafler DA. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol Nov 2007;191(1-2):70-8. (Pubitemid 350061001)
27. Xu YQ, Gao YD, Yang J, Guo W. A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J Asthma May 2010;47(4):367-73.
28. Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol Mar 1 2006;176(5):3215-22.
29. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003;108:1232-7. (Pubitemid 37099993)
30. Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, et al. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol Lett Jan 4 2010;127:150-6.
31. Charbonnier LM, Han WG, Quentin J, Huizinga TW, Zwerina J, Toes RE, et al. Adoptive transfer of IL-10-secreting CD4+CD49b+regulatory T cells suppresses ongoing arthritis. J Autoimmun Jun 2010;34:390-9.